ARUP’s Employee Advisory Council, pictured here with CEO Andy Theurer and Santa, lead the employee charitable giving program. In 2021, ARUP raised a record $82K for nonprofits that work to cure cancer, improve community health, provide STEM education, prevent suicide, and support those affected by suicide. |
January 20, 2022 |
Topping $82K, Annual Charitable Donations Set New Milestone for ARUP Whatever you call it—altruism, generosity, or simply paying it forward—the act of serving and giving to others is a tenant central to ARUP that goes well beyond the work performed in our labs. |
ARUP Consult, a free source of laboratory testing information for clinicians, released several updated resources in December. |
January 4, 2022 |
ARUP Consult Provides Updated Resources on Testing for Celiac Disease and Trace Elements ARUP Consult®, a free source of expert guidance in laboratory testing, has released updated resources on testing for celiac disease and trace element deficiency and toxicity. |
December 17, 2021 | On December 10, 2021, a Common Vulnerability and Exposure (CVE) alert was issued from NIST related to Apache Log4j, CVE-2021-44228. |
|
December 16, 2021 |
ARUP’s Rick Panning: Let’s Fix Reimbursements and Preserve Quality Patient Care Tucked inside the bill that President Biden signed to raise the national debt ceiling was a holiday gift for clinical laboratories and Medicare patients. |
|
December 8, 2021 |
ARUP Earns Fourth Consecutive Utah Business Best Companies to Work For Award For the fourth consecutive year, Utah Business magazine has honored ARUP Laboratories with its Best Companies to Work For award. ARUP is one of 65 companies to earn the award. |
|
ARUP Consult, a free source with laboratory testing information for clinicians, released several updated resources in November. |
December 2, 2021 |
ARUP Consult: Resources on Testing for Hereditary Thrombophilia, Group B Streptococcus, and PNS ARUP Consult® has released updated resources on Hereditary Thrombophilia, Group B Streptococcal Disease, and Paraneoplastic Neurologic Syndromes (PNSs). |